Displaying archives for February 2018 - ALCMI - Addario Lung Cancer Medical Institute:

Motivated Patients with ROS1 Cancer Initiate Global Research Study

Posted by Bradley Newton on February 21st, 2018 |

Global collaboration among data scientists, engineers, developers, coders, radiologists and physicians to end the world’s deadliest cancer. The Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology (NASDAQ: CSBR) and the ROS1ders announce the commencement of a global study to gain a deeper understanding of ROS1-positive cancer. The study is developing patient-derived xenografts (PDX) models for […]